Detalles de la búsqueda
1.
Carfilzomib or bortezomib in combination with cyclophosphamide and dexamethasone followed by carfilzomib maintenance for patients with multiple myeloma after one prior therapy: results from a multicenter, phase II, randomized, controlled trial (MUKfive).
Haematologica
; 106(10): 2694-2706, 2021 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33910333
2.
An early post-transplant relapse prediction score in multiple myeloma: a large cohort study from the chronic malignancies working party of EBMT.
Bone Marrow Transplant
; 58(8): 916-923, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37160942
3.
Defining Unmet Need Following Lenalidomide Refractoriness: Real-World Evidence of Outcomes in Patients With Multiple Myeloma.
Front Oncol
; 11: 703233, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34367987
4.
Unplanned admissions for patients with myeloma in the UK: Low frequency but high costs.
J Bone Oncol
; 17: 100243, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31223562
5.
Correction: An early post-transplant relapse prediction score in multiple myeloma: a large cohort study from the chronic malignancies working party of EBMT.
Bone Marrow Transplant
; 58(9): 1065, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37316543
Resultados
1 -
5
de 5
1
Próxima >
>>